208 related articles for article (PubMed ID: 9176080)
1. Micrometastases: marker of metastatic potential or evidence of residual disease?
O'Sullivan GC; Collins JK; Kelly J; Morgan J; Madden M; Shanahan F
Gut; 1997 Apr; 40(4):512-5. PubMed ID: 9176080
[TBL] [Abstract][Full Text] [Related]
2. Micrometastases in bone marrow of patients undergoing "curative" surgery for gastrointestinal cancer.
O'Sullivan GC; Collins JK; O'Brien F; Crowley B; Murphy K; Lee G; Shanahan F
Gastroenterology; 1995 Nov; 109(5):1535-40. PubMed ID: 7557136
[TBL] [Abstract][Full Text] [Related]
3. Detection of bone marrow micrometastases in the rib marrow of head and neck cancer patients: a prospective pilot study.
Skinner LJ; Conlon BJ; Russell JD; O'sullivan GC; O'dwyer TP
Eur Arch Otorhinolaryngol; 2005 Feb; 262(2):103-6. PubMed ID: 15197562
[TBL] [Abstract][Full Text] [Related]
4. Bone-marrow micrometastases in patients with brain metastases from epithelial cell tumours.
Maguire D; O'Sullivan GC; McNamara B; Collins JK; Shanahan F
QJM; 2000 Sep; 93(9):611-5. PubMed ID: 10984556
[TBL] [Abstract][Full Text] [Related]
5. [Micrometastases in patients with colorectal cancer: markers for metastatic potential or proofs for residual disease].
Iovchev I; Trifonov D; Popkharitov A; Khadzhipetkov F; Nikolov S
Khirurgiia (Sofiia); 2004; 60(4-5):18-21. PubMed ID: 16042058
[TBL] [Abstract][Full Text] [Related]
6. Micrometastases in esophagogastric cancer: high detection rate in resected rib segments.
O'sullivan GC; Sheehan D; Clarke A; Stuart R; Kelly J; Kiely MD; Walsh T; Collins JK; Shanahan F
Gastroenterology; 1999 Mar; 116(3):543-8. PubMed ID: 10029612
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression in primary human colorectal cancers and bone marrow micrometastases.
Sheehan KM; Cahill RA; McGreal G; Steele C; Byrne MF; Kirwan WO; Kay EW; Fitzgerald DJ; Redmond HP; Murray FE
Dig Liver Dis; 2004 Jun; 36(6):392-7. PubMed ID: 15248379
[TBL] [Abstract][Full Text] [Related]
8. Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
Slade MJ; Singh A; Smith BM; Tripuraneni G; Hall E; Peckitt C; Fox S; Graham H; Lüchtenborg M; Sinnett HD; Cross NC; Coombes RC
Int J Cancer; 2005 Mar; 114(1):94-100. PubMed ID: 15523696
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow micrometastases and gastrointestinal cancer detection and significance.
Maguire D; O'Sullivan GC; Collins JK; Morgan J; Shanahan F
Am J Gastroenterol; 2000 Jul; 95(7):1644-51. PubMed ID: 10925963
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow micrometastases and markers of angiogenesis in esophageal cancer.
Spence GM; Graham AN; Mulholland K; Maxwell P; McCluggage WG; Sloan JM; McGuigan JA
Ann Thorac Surg; 2004 Dec; 78(6):1944-9; discussion 1950. PubMed ID: 15561005
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
Braun S; Pantel K; Müller P; Janni W; Hepp F; Kentenich CR; Gastroph S; Wischnik A; Dimpfl T; Kindermann G; Riethmüller G; Schlimok G
N Engl J Med; 2000 Feb; 342(8):525-33. PubMed ID: 10684910
[TBL] [Abstract][Full Text] [Related]
12. Biological characteristics of micrometastatic cancer cells in bone marrow.
Braun S; Pantel K
Cancer Metastasis Rev; 1999; 18(1):75-90. PubMed ID: 10505547
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow micrometastases predict early post-operative recurrence following surgical resection of oesophageal and gastric carcinoma.
Macadam R; Sarela A; Wilson J; MacLennan K; Guillou P
Eur J Surg Oncol; 2003 Jun; 29(5):450-4. PubMed ID: 12798750
[TBL] [Abstract][Full Text] [Related]
14. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.
Schoenfeld A; Kruger KH; Gomm J; Sinnett HD; Gazet JC; Sacks N; Bender HG; Luqmani Y; Coombes RC
Eur J Cancer; 1997 May; 33(6):854-61. PubMed ID: 9291805
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of bone marrow micrometastases in esophagogastric cancer patients with and without neoadjuvant chemoradiotherapy.
Ryan P; McCarthy S; Kelly J; Collins JK; Dunne C; Grogan L; Breathnach O; Shanahan F; Carey PD; Walsh TN; O'Sullivan GC
J Surg Res; 2004 Mar; 117(1):121-6. PubMed ID: 15013722
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma.
Janni W; Gastroph S; Hepp F; Kentenich C; Rjosk D; Schindlbeck C; Dimpfl T; Sommer H; Braun S
Cancer; 2000 May; 88(10):2252-9. PubMed ID: 10820346
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis.
Thorban S; Rosenberg R; Busch R; Roder RJ
Br J Cancer; 2000 Jul; 83(1):35-9. PubMed ID: 10883665
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia.
Bonavina L; Soligo D; Quirici N; Bossolasco P; Cesana B; Lembertenghi Deliliers G; Peracchia A
Surgery; 2001 Jan; 129(1):15-22. PubMed ID: 11150029
[TBL] [Abstract][Full Text] [Related]
19. [Micrometastatic cells in the bone marrow of patients with breast carcinoma].
Diel IJ; Solomayer EF; Bastert G
Radiologe; 2000 Aug; 40(8):681-7. PubMed ID: 11006937
[TBL] [Abstract][Full Text] [Related]
20. Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study.
Langer I; Guller U; Koechli OR; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M;
Ann Surg Oncol; 2007 Jun; 14(6):1896-903. PubMed ID: 17356955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
